MDMB-5Me-INACA

The following information was compiled in November 2023 and is subject to change as new research is conducted and as new information becomes available:

Description: MDMB-5Me-INACA is a synthetic cannabinoid precursor that could be used to produce structurally related synthetic cannabinoid final products. Synthetic cannabinoid precursors (e.g., MDMB-INACA, ADB-INACA, MDMB-5’Br-INACA) began appearing after the implementation of a national class-wide synthetic cannabinoid scheduling action imposed by China in July 2021.

Sample Source: NMS Labs – Drug Chemistry

Sample Appearance: Paper containing no visible residue

Pharmacology: The activity and potency of MDMB-5Me-INACA are unknown; however, based on structurally similar synthetic cannabinoid precursors, MDMB-5Me-INACA is expected to be inactive or have low potency.

Toxicology: MDMB-5Me-INACA has not been detected in toxicology cases at the CFSRE.

Drug Materials: MDMB-5Me-INACA has been detected in one drug material at the CFSRE.

Demographics / Geographics: The drug material originated from the state of New York.

Legal Status: MDMB-5Me-INACA is not explicitly scheduled in the United States.

Class:

Cannabinoid

Appearance:

Paper

Formula:

C16H21N3O3

MW:

303.4

[M+]:

303

[M+H]+:

304.1656

IUPAC:

methyl 3,3-dimethyl-2-[(5-methyl-1H-indazole-3-carbonyl)amino]butanoate

Report Date:

November 21, 2023